key: cord-0703092-xklbnvom authors: Wang, Zhihua; Li, Huijun; Li, Jingjing; Yang, Chunguang; Guo, Xiaolin; Hu, Zhiquan; Chen, Zhiqiang; Wang, Shaogang; Liu, Jihong title: Elevated serum IgM levels indicate poor outcome in patients with coronavirus disease 2019 pneumonia: A retrospective case-control study date: 2020-03-27 journal: nan DOI: 10.1101/2020.03.22.20041285 sha: 2573ffd894fbd9dfee6f5e72697d0d9740540677 doc_id: 703092 cord_uid: xklbnvom Background: The coronavirus disease 2019 (COVID-19) pneumonia outbreak began in Wuhan and pandemics tend to occur. Although SARS-CoV-2-specific immunoglobulins have been detected in serum of COVID-19 patients, their dynamics and association with outcomes have not been characterized. Methods: A total of 116 hospitalized patients with confirmed COVID-19 pneumonia and SARS-CoV-2-specific immunoglobulins tested in Tongji hospital were retrospectively investigated. Clinical, laboratory, radiological characteristics and outcomes data were compared between mild-moderate group and died group. Further, a paired case-control study was conducted where each deceased case was matched to three mild-moderate patients of similar age. Findings: Among 116 subjects included, 101 mild-moderate patients survived and 15 cases died. SARS-CoV-2-specific IgM levels peaked in forth week after onset of COVID-19 pneumonia, while serum IgG levels increased over 8 weeks. Serum IgM levels were higher in deceased patients than mild-moderate patients (P = 0.024), but not IgG. Serum IgM levels were negatively correlated with clinical outcome, eosinophil count and albumin levels (r = -0.269, P = 0.003; r = -0.188, P = 0.043; and r = -0.198, P = 0.033, resp.). The area under the ROC curve (AUC) for IgM antibody was 0.681 (95% CI: 0.517-0.845, P = 0.024). In case-control study paired by age, serum IgM was higher in deceased patients than mild-moderate patients (P = 0.019), positively correlated with leucocyte count (r = 0.260, P = 0.045), while negatively correlated with clinical outcome and albumin levels (r = -0.337, P = 0.008; r = -0.265, P = 0.041). AUC for IgM levels was 0.704 (95% CI: 0.534-0.873, P = 0.019). Interpretation: These results indicate that dynamics of SARS-CoV-2 specific IgM and IgG antibodies was similar with that of SARS-CoV, while elevated serum IgM levels indicate poor outcome in patients with COVID-19 pneumonia. Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide since its discovery in December 2019 1, 2 . As of March 14, 2020, over five thousand death from 2019 novel coronavirus (SARS-CoV-2) infection have been reported in 43 countries 3 . Effective strategies to treat this disease are urgently needed, but no drugs have been proven to be effective for the treatment of COVID-19 pneumonia 4 . Antibodies are key components in the immune responses to viral infections 5, 6 . Raised SARS-CoV-2-specific immunoglobulin M (IgM) and immunoglobulin G (IgG) have been detected in serum of COVID-19 patients 7 . However, less information is available about their dynamics and role in COVID-19 pneumonia. Therefore, 116 hospitalized patients with COVID-19 pneumonia and with SARS-CoV-2 specific serum IgM and IgG detected were retrospectively selected between February 23, 2020, and March 11, 2020. The dynamics and role of serum IgM and IgG were investigated in this study. A total of 116 hospitalized patients with confirmed COVID-19 pneumonia and with serum IgM and IgG against SARS-CoV-2 examined between February 23, 2020, and March 11, 2020 in Tongji Hospital were retrospectively investigated. In brief, the patients in mild-moderate group described here were all probable hospitalized subjects in four wards of Tongji hospital with (1) serum IgM and IgG against SARS-CoV-2 examined, (2) chest radiographic evidence of pneumonia, (3) positive throat swab nucleic acid test by real-time RT-PCR methods or were excluded from this study. This study was reviewed and approved by the Medical Ethical Committee of Tongji Hospital of Huazhong University of Science and Technology (IRB ID：TJ-IRB20200343). Information collection was accomplished through our hospital's electronic medical record system. Clinical, laboratory, radiological parameters and clinical outcomes were obtained with standardised forms for all subjects involved. Two researchers independently reviewed the data. Serum IgM and IgG antibodies were detected by the chemiluminescence kit (iFlash-SARS-CoV-2 IgM, iFlash-SARS-CoV-2 IgG) and iFlash 3000 CLIA System supplied by Yhlo Biotech Co. LTD (Shenzhen, China), of which the chemiluminescence kit had completed the EU CE certification. Threshold of 10 AU/ml was used for both IgM and IgG as manufacturer recommended. The statistical software SPSS 23.0 was used in this study. Categorical variables were described as frequency rates and percentages, and continuous variables were described using mean with interquartile range (IQR). When the data were normal, continuous variables were analysed by t tests, otherwise using the Mann-Whitney test. The blood counts of patients on admission showed significantly decrease in lymphocytes, especially in died group than in mild-moderate patients ( Table 2) . Figure 1A , B). We subsequently explored the correlations between IgM levels and clinical outcome, serum IgG levels, blood counts, or other involved parameters. Interestingly, serum IgM levels were positively correlated with IgG levels (r = 0.251, P = 0.006), while negatively correlated with clinical outcome, eosinophil count and All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1D ). As reported, antibodies to coronaviruses are higher in older compared with younger adults 9 . To minimize confounding effects from age, a paired case-control study was further done. Each deceased case was matched with three mild-moderate patients of similar age (age difference within four years). Leucocyte count and neutrophil count of patients on admission were significantly higher in died group than mild-moderate All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 2A ). We also explored the correlations between IgM levels and clinical outcome, serum IgG levels, blood counts, or other involved parameters. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . This study also has limitations. It is a single-centre retrospective study with limited cases. Majority of patients admitted in our hospital were critically ill, so population bias exists. In addition, results of viral load and antibody re-testing were not available. In summary, our results demonstrate that dynamics of IgM and IgG antibodies against SARS-CoV-2 was similar with that of SARS-CoV. Differently, elevated serum IgM levels indicate poor outcome in patients with COVID-19 pneumonia. ZH, XG and ZC made substantial contributions to the study design. JL and ZW was in charge of the manuscript draft. ZW and HL took responsibility for obtaining ethical approval. CY and ZH took responsibility for data acquisition. CY and JL made main contributions to data analysis and interpretation. JL and HL participated in the diagnosis and treatment of health professionals. ZC and SW made substantial revisions to the manuscript. The authors declare no conflict of interest. With the permission of the corresponding authors, the raw data without names and identifiers are available on reasonable request. Data can be provided after publication of this study. Once the data are approved to be made public, the researchers will provide an email address for communication. The corresponding authors will make a decision based on the research objectives and plan provided. This work was supported by National Natural Science Foundation of China (No.81702989) All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. (A) Serum IgM levels were significantly higher in died group in case-control study. (D) Accuracy of serum IgM levels in predicting the mortality of paired patients. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 27, 2020. . https://doi.org/10.1101/2020.03.22.20041285 doi: medRxiv preprint Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study A Novel Coronavirus from Patients with Pneumonia in China Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Antibody Therapy for the Control of Viral Diseases: An Update Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses Early dynamics of transmission and control of COVID-19: a mathematical modelling study Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome